maryland defective drug law firm

AbbVie Hit with $150M Verdict in “Low-T” Trial

The first jury verdict in a series of bellwether trials involving the testosterone treatment AndroGel is in. The jury found that the manufacturer of the gel, AbbVie, should pay $150 Read More

, , , , , , , , ,
Low T Comments (0)
Contact Form

Do I have a Case?

Contact us at the Yost Legal Group for a free initial consultation. We can help to provide information about ongoing litigation or discuss the circumstances of your individual case. There is no fee or expense unless you recover.